Received: 23 November 2019
Accepted: 30 January 2020
First Online: 10 February 2020
Compliance with Ethical Standards
: GN reports personal fees from CareFusion and Teleflex. TC owns stock in Forge Medical, reports personal fees from Teleflex, Merit and Becton–Dickinson and research funding from Surmodics. The remaining authors declare that they have no conflict of interest.
: Not applicable; all patient data were protected under the Health Insurance Portability and Affordability Act (HIPPA).
: For this type of study formal consent is not required.
: For this type of study informed consent is not required.